Bingfeng Zheng Selected Research

Immunotherapy

10/2019

Role of CXCR3 signaling in response to anti-PD-1 therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bingfeng Zheng Research Topics

Disease

2	Neoplasms (Cancer) 01/2021 - 10/2019
1	Foreign Bodies (Foreign Body) 11/2023
1	Non-alcoholic Fatty Liver Disease 01/2023
1	Gallbladder Diseases (Gall Bladder Disease) 01/2023
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023
1	Pathologic Constriction (Stenosis) 01/2022
1	Nodular Goiter 01/2022
1	COVID-19 06/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019
1	Colitis 01/2017
1	Inflammation (Inflammations) 01/2017

Drug/Important Bio-Agent (IBA)

2	Folic Acid (Vitamin M)FDA LinkGeneric 01/2023 - 01/2021
1	alpha-Linolenic Acid (Linolenic Acid)IBA 01/2023
1	Messenger RNA (mRNA)IBA 06/2021
1	fraxinelloneIBA 01/2021
1	Carrier Proteins (Binding Protein)IBA 01/2021
1	pembrolizumabIBA 10/2019
1	PlatinumIBA 01/2019
1	sym-trinitrobenzeneIBA 01/2017
1	Sulfonic AcidsIBA 01/2017
1	fumigaclavine CIBA 01/2017
1	Interferon-gamma (Interferon, gamma)IBA 01/2017

Therapy/Procedure

2	Laparoscopic Cholecystectomy 11/2023 - 01/2023
1	Anesthesia 01/2022
1	Extracorporeal Membrane Oxygenation 01/2022
1	Intraperitoneal Injections 10/2019
1	Immunotherapy 10/2019
1	Drug Therapy (Chemotherapy) 01/2019